Stock Research: Cochlear

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Cochlear

ASX:COH AU000000COH5
11
  • Value
    39
  • Growth
    69
  • Safety
    Safety
    13
  • Combined
    19
  • Sentiment
    26
  • 360° View
    360° View
    11
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Cochlear Limited provides implantable hearing solutions. The company operates in the medical devices industry, specifically in hearing implants and related services. They operate globally, with a focus on providing solutions for hearing loss. In the last fiscal year, the company had a market cap of $12,783 million, profits of $1,130 million, and revenue of $1,490 million with 5000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 11 (better than 11% compared with alternatives), overall professional sentiment and financial characteristics for the stock Cochlear are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Cochlear. The consolidated Growth Rank has a good rank of 69, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 69% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 13 means that the share price of Cochlear is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 87% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 39, which means that the company has a riskier financing structure than 61% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 26, indicating professional investors are more pessimistic about the stock than for 74% of alternative investment opportunities. ...read more

more
Index
ASX 100
ASX 200
ASX 300
ASX 50
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
13 13 10 23
Growth
69 21 89 45
Safety
Safety
39 41 50 55
Sentiment
26 14 39 27
360° View
360° View
11 1 41 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
11 23 3 19
Opinions Change
28 10 55 44
Pro Holdings
n/a 25 66 37
Market Pulse
74 77 76 71
Sentiment
26 14 39 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
13 13 10 23
Growth
69 21 89 45
Safety Safety
39 41 50 55
Combined
19 4 52 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
14 9 12 22
Price vs. Earnings (P/E)
9 7 5 19
Price vs. Book (P/B)
7 5 5 13
Dividend Yield
41 47 46 46
Value
13 13 10 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
77 65 59 54
Profit Growth
67 44 72 50
Capital Growth
41 18 47 33
Stock Returns
55 13 91 57
Growth
69 21 89 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
63 56 61 58
Refinancing
23 18 23 37
Liquidity
55 57 56 50
Safety Safety
39 41 50 55

Similar Stocks

Discover high‑ranked alternatives to Cochlear and broaden your portfolio horizons.

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Flight Centre Travel

ASX:FLT
Country: Australia
Industry: Hotels, Resorts & Cruise Lines
Size: Medium
Full Stock Analysis

MediPal Holdings

TSE:7459
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.